Establishing secure connection…Loading editor…Preparing document…

Research Ethical Clearance Letter

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH ETHICAL CLEARANCE LETTER

Committee Name:

Committee Address:

Letter Number:    Approval Date:

RECITALS

WHEREAS, the Research Ethics Committee (hereinafter "the Committee") has conducted a full review of the research protocol submitted by the Principal Investigator and has assessed the proposed activities for compliance with applicable ethical standards, protections for human subjects, and institutional policies;

WHEREAS, the Principal Investigator has submitted documentation including the protocol, informed consent forms, recruitment materials, and data management plans, and has represented that the study will be conducted in accordance with the protocol and any legally applicable requirements governing human subjects research;

WHEREAS, the Committee's clearance is granted subject to the conditions and obligations set forth below, and such clearance does not constitute a transfer of liability from the Principal Investigator or their institution for compliance with applicable laws and institutional policies;

PROJECT IDENTIFICATION

SCOPE OF WORK

This clearance authorizes the Principal Investigator to undertake the activities described above in accordance with the submitted protocol and any conditions listed in this letter. Any deviation from the approved protocol requires prior written approval from the Committee.

MONITORING, REPORTING AND AMENDMENTS

The Principal Investigator shall submit progress reports to the Committee at the following interval: . Any unanticipated problems, serious adverse events, or proposed substantive amendments must be reported promptly and in writing.

PAYMENT TERMS

Administrative Fee Amount: (USD)

Late Payment Penalty (annualized):

Failure to pay required administrative fees within thirty (30) days of invoice may result in suspension of the clearance until payment is received.

TERM AND TERMINATION

Authorized Start Date:    Authorized End Date:

The Committee reserves the right to suspend or terminate this clearance immediately where there is a determination of noncompliance, risk to participants, or other substantial grounds. The Principal Investigator may terminate the study by giving written notice to the Committee in accordance with the notice period above.

CONFIDENTIALITY AND DATA HANDLING

All study data, including personally identifiable information and identifiable biospecimens, shall be stored, accessed, and disposed of in accordance with the data management plan and applicable law. The Principal Investigator shall implement safeguards to preserve participant confidentiality and shall limit access to authorized personnel only.

The Principal Investigator warrants that data will not be shared with third parties except as provided in the approved protocol or with prior written approval of the Committee.

INDEMNITY AND LIABILITY

The Principal Investigator and the institution accept responsibility for ensuring that the research is conducted in accordance with the approved protocol and applicable laws. The Committee's issuance of clearance does not relieve the Principal Investigator or their institution of legal responsibility or indemnify them against claims arising from the conduct of the research.

GOVERNING LAW

This clearance letter and any dispute arising out of or related to it shall be governed by and construed in accordance with the laws of the jurisdiction in which the Committee is located.

ENTIRE AGREEMENT

This letter, together with the approved protocol and any written conditions attached hereto, constitutes the entire agreement between the Committee and the Principal Investigator with respect to the subject matter herein and supersedes all prior representations or agreements, whether written or oral.

ACKNOWLEDGMENT

By signing below, the Principal Investigator acknowledges receipt of this clearance, accepts the conditions set forth, and agrees to comply with all reporting and monitoring obligations imposed by the Committee.

Principal Investigator:

By:

Date:

Committee Representative:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What a Research Ethical Clearance Letter Is

The Research Ethical Clearance Letter is an official, signed document issued by an institutional review board or equivalent ethics committee confirming that a proposed study has been reviewed and meets applicable ethical standards for research involving human subjects. It typically states the project title, principal investigator, approved procedures, approved recruitment and consent materials, approval date, and any conditions or expirations. The letter is used by investigators to demonstrate institutional approval for data collection, grant reporting, journal submission, international collaboration, and regulatory and funding compliance.

Why the Clearance Letter Matters

A Research Ethical Clearance Letter documents IRB approval, confirms participant protections and consent processes, and provides an auditable record for sponsors, journals, and institutional administrators. Many journals, funders, and foreign institutions require it to verify ethical oversight before permitting data use or publication.

Why the Clearance Letter Matters

Who Requests and Relies on This Letter

Common users include investigators, research coordinators, IRB administrators, and institutional compliance officers who manage approvals and documentation.

  • Principal investigators — to show ethical approval for data collection, publication, and grant compliance.
  • Sponsors and funders — to confirm reviewed protocols and participant protections before releasing funds.
  • Journals and conference organizers — to validate IRB oversight required for human-subjects research.

Institutions also use the letter for regulatory audits, study closeout, and multi-site reliance agreements where proof of local approval is required.

Core Elements to Include in a Professional Clearance Letter

Essential sections of a Research Ethical Clearance Letter clarify approval scope, conditions, dates, and any required reporting or monitoring requirements.

Project ID

Include the assigned protocol or project identifier used by the IRB and sponsor; ensures accurate cross-referencing across submission systems, progress reports, and any multi-site reliance documentation.

Principal Investigator

Provide the PI's full name, institutional affiliation, and contact details to identify who is responsible for study conduct, reporting, and responding to conditions or safety concerns during the approved study.

Scope of Approval

Describe the approved activities, target population, recruitment methods, consent approach, and any excluded procedures or populations so recipients understand the limits of authorized work.

Conditions

List stipulations imposed by the IRB such as required consent revisions, staff training, periodic reporting intervals, data security measures, or active monitoring requirements and timelines.

Approval Period

State the approval effective date and expiration date along with continuing review requirements and procedures for timely amendment submissions and adverse-event reporting.

Signatory

Provide the name, title, signature date, and institutional contact for the IRB chair or authorized official, and confirm issuance on official letterhead for verification purposes.

Required Data Fields at a Glance

Protocol Number: IRB-assigned ID
PI Name: Full legal name
Approval Date: MM/DD/YYYY
Expiration Date: MM/DD/YYYY or 'No expiration'
Approved Activities: Scope summary
Conditions: IRB stipulations

Step-by-Step: Obtain and Issue the Clearance Letter

Follow these steps to prepare and obtain a Research Ethical Clearance Letter from your IRB.

  • 01
    Prepare protocol: Complete IRB application and supporting materials.
  • 02
    Submit package: Upload application, consent forms, and instruments.
  • 03
    Respond to queries: Address IRB requests promptly and submit revisions.
  • 04
    Receive letter: Obtain signed clearance letter and retain records.

Configure an Online Clearance Request Workflow

Configure an online intake form and eSubmission workflow to streamline institutional clearance letter requests and routing to the IRB office.

Field Configuration
Submission Type New, amendment, or continuing review
Required Docs Protocol, consent, instruments, investigator CVs
Routing IRB admin to reviewers to chair
Notifications Email confirmations and reminder alerts to PI

Where to Send and How It Moves Through the IRB

Typical routing for a clearance request, from investigator submission to IRB sign-off and distribution to stakeholders.

  • Submit to IRB: Upload complete package to institutional IRB portal.
  • IRB review: Administrative check, assigned reviewers, and convened meeting if required.
  • Approval issued: Signed clearance letter produced and dated by authorized official.
  • Distribute letter: Share to sponsors, funders, journals, or collaborating sites.

Digital Signing and eSubmission Requirements

Use secure eSubmission and eSignature platforms that meet institutional and federal requirements, including audit trails and access controls.

  • File Formats: PDF/A preferred; Word DOCX accepted
  • Authentication: Email code, MFA, or institutional SSO
  • Integrations: Connect to NetSuite, Google Workspace, or Box

Typical Processing Times and Deadlines

Processing times and review deadlines vary; plan ahead for continuing review, amendments, and multi-site reliance agreements.

Initial review time:

Often 4–8 weeks depending on IRB workload.

Expedited review:

Often 1–3 weeks for minimal-risk protocols.

Amendment review:

Allow 2–6 weeks for modifications and updated consent.

Continuing review:

Annual or as required by IRB; notify on schedule.

Multi-site reliance:

Additional time for reliance agreements and communications.

Common Mistakes That Delay Clearance

  • Incomplete documentation — missing final consent forms, unclear recruitment scripts, or absent data instruments trigger administrative returns and delay approval timelines by weeks.
  • Name mismatches — PI or institution names that differ from sponsor or grant documentation can prevent issuance of a clearance letter until corrected.
  • Incorrect dates or version numbers — submitting outdated consent forms or unversioned documents can invalidate approval and require resubmission.
  • Failure to include IRB stipulations — not addressing required conditions or training can lead to conditional approvals or suspension of approval.

Consequences of an Incorrect or Missing Letter

Regulatory Noncompliance: Fines, audit findings, funding risk
Publication Denial: Journals may reject manuscripts
Funding Suspension: Grants paused or revoked
Participant Harm: Ethical breaches risk safety
Data Inadmissible: Institution refuses data use
Legal Exposure: Civil or administrative liability

Real-World Use Cases and Common Outcomes

Two concise examples illustrate how missing items delay approval and how corrected submissions lead to issuance and downstream acceptance.

University Study

A university social‑behavior study received delayed IRB clearance due to missing consent form versions in the submission package.

  • They corrected documents and resubmitted.
  • After inclusion of version-controlled consent PDFs and a complete protocol, the IRB issued a signed Research Ethical Clearance Letter; the team updated sponsors and proceeded with recruitment under the approved conditions.

Community Clinic Trial

A community clinic conducting minimal-risk observational research needed proof of ethical oversight for a multi-site data sharing agreement.

  • The IRB required a data security plan.
  • By attaching the approved data security addendum and obtaining a signed Research Ethical Clearance Letter, the clinic satisfied collaborating sites and executed data transfer agreements with institutional signatories and sponsor compliance checks.

Who Signs and Attests to This Letter

IRB Chair

The IRB chair or designated official signs and issues the Research Ethical Clearance Letter after full review. That signature constitutes the institutional attestation of approval, any conditions, and the authorized point of contact for verification, and must be supported by retained records.

Principal Investigator

The principal investigator requests clearance, submits required materials, and implements IRB conditions. The PI must maintain the clearance letter, report adverse events, and provide the document to sponsors, journals, and auditors when requested.

eSignature Vendor Pricing Comparison for Clearance Letters

Compare typical starting prices and core features for eSignature providers commonly used to obtain and distribute clearance letters.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies Varies Varies

Frequently Asked Questions: Clearance Letter Issues

Answers to common questions about issuing, signing, and using Research Ethical Clearance Letters, including electronic submission and retention.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.